Guardant Health (GH)
(Delayed Data from NSDQ)
$17.35 USD
+0.19 (1.11%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.36 +0.01 (0.06%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Guardant Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 564 | 450 | 374 | 287 | 214 |
Cost Of Goods | 227 | 156 | 123 | 93 | 71 |
Gross Profit | 337 | 293 | 251 | 194 | 144 |
Selling & Adminstrative & Depr. & Amort Expenses | 902 | 838 | 662 | 449 | 226 |
Income After Depreciation & Amortization | -565 | -544 | -411 | -255 | -82 |
Non-Operating Income | 89 | -106 | 29 | 14 | 14 |
Interest Expense | 3 | 3 | 3 | 5 | 1 |
Pretax Income | -479 | -653 | -384 | -246 | -70 |
Income Taxes | 1 | 1 | 0 | 0 | -2 |
Minority Interest | 0 | 0 | 21 | 8 | 8 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -479 | -655 | -385 | -246 | -68 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -479 | -655 | -406 | -254 | -76 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -533 | -501 | -373 | -230 | -71 |
Depreciation & Amortization (Cash Flow) | 32 | 43 | 38 | 25 | 11 |
Income After Depreciation & Amortization | -565 | -544 | -411 | -255 | -82 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 111.99 | 102.18 | 101.31 | 97.50 | 90.60 |
Diluted EPS Before Non-Recurring Items | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 |
Diluted Net EPS (GAAP) | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 |
Fiscal Year end for Guardant Health, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 155.05 | 143.03 | 137.15 | 128.71 |
Cost Of Goods | NA | 62.52 | 57.61 | 53.85 | 53.07 |
Gross Profit | NA | 92.54 | 85.42 | 83.30 | 75.64 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 206.65 | 198.96 | 202.92 | 209.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -114.11 | -113.54 | -119.62 | -134.06 |
Non-Operating Income | NA | 10.57 | 28.58 | 47.99 | 1.41 |
Interest Expense | NA | 0.65 | 0.64 | 0.65 | 0.64 |
Pretax Income | NA | -187.58 | -85.61 | -72.28 | -133.29 |
Income Taxes | NA | -0.54 | 0.49 | 0.50 | 0.24 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -187.04 | -86.10 | -72.77 | -133.53 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -187.04 | -86.10 | -72.77 | -133.53 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 118.51 | 117.74 | 108.81 | 102.66 |
Diluted EPS Before Non-Recurring Items | NA | -1.58 | -0.73 | -0.67 | -1.30 |
Diluted Net EPS (GAAP) | NA | -1.58 | -0.73 | -0.67 | -1.30 |